Nationwide survey of refractory asthma with bronchiectasis by inflammatory subtypes.
Nomura N, Matsumoto H, Yokoyama A, Nishimura Y, Asano K, Niimi A, Tohda Y, Harada N, Nagase H, Nagata M, Inoue H, Kondo M, Horiguchi T, Miyahara N, Hizawa N, Hojo M, Hattori N, Hashimoto N, Yamasaki A, Kadowaki T, Kimura T, Miki M, Taniguchi H, Toyoshima M, Kawamura T, Matsuno O, Sato Y, Sunadome H, Nagasaki T, Oguma T, Hirai T; BEXAS study.
Respir Res. 2022 Dec 20;23(1):365. doi: 10.1186/s12931-022-02289-y.
PMID:36539765
Molecular Targets for Biological Therapies of Severe Asthma.
Pelaia C, Crimi C, Vatrella A, Tinello C, Terracciano R, Pelaia G.
Front Immunol. 2020 Nov 30;11:603312. doi: 10.3389/fimmu.2020.603312. eCollection 2020.
PMID:33329598
JAK3 inhibitor suppresses multipotent ILC2s and attenuates steroid-resistant asthma.
Kim J, Ham J, Kang HR, Bae YS, Kim T, Kim HY.
Sci Adv. 2023 Dec 22;9(51):eadi3770. doi: 10.1126/sciadv.adi3770. Epub 2023 Dec 20.